HealthLynked Corp. (HLYK)
OTCMKTS
· Delayed Price · Currency is USD
0.0181
-0.0018 (-9.05%)
May 27, 2025, 3:19 PM EDT
HealthLynked Revenue
HealthLynked had revenue of $774.21K in the quarter ending March 31, 2025, a decrease of -22.91%. This brings the company's revenue in the last twelve months to $2.78M, down -44.11% year-over-year. In the year 2024, HealthLynked had annual revenue of $3.01M, down -47.43%.
Revenue (ttm)
2.78M
Revenue Growth
-44.11%
P/S Ratio
1.98
Revenue / Employee
138.92K
Employees
20
Market Cap
5.50M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.01M | -2.71M | -47.43% |
Dec 31, 2023 | 5.72M | -135.82K | -2.32% |
Dec 31, 2022 | 5.86M | -638.93K | -9.83% |
Dec 31, 2021 | 6.50M | 1.13M | 21.09% |
Dec 31, 2020 | 5.37M | 1.35M | 33.51% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
BioStem Technologies | 332.45M |
HealthLynked News
- 6 weeks ago - HealthLynked Welcomes Anthony Scuilla as Sales Consultant to Drive Strategic Partnerships with Insurance Providers - GlobeNewsWire
- 4 months ago - HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future - GlobeNewsWire
- 4 months ago - HealthLynked apppoints Jeremy Daniel as CFO - Seeking Alpha
- 4 months ago - HealthLynked Welcomes Jeremy Daniel as Chief Financial Officer - GlobeNewsWire
- 6 months ago - HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus - GlobeNewsWire
- 10 months ago - HealthLynked GAAP EPS of -$0.01, revenue of $0.8M - Seeking Alpha
- 10 months ago - HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services - GlobeNewsWire
- 10 months ago - HealthLynked Partners with RxSpark to Enhance Medication Access and Management for Patients - GlobeNewsWire